Home » Medical Devices » Asthma Spacers Market

Asthma Spacers Market By Product (Aerochamber, Inspirease, Optichamber and Volumatic), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and E-Commerce) – Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Summary
Table Of Content

Market Insights

The asthma spacers market is expected to grow at a compound annual growth rate (CAGR) of 3.8% between 2018 and 2026, from US$ 1,311.1 million in 2017 to US$ 1,824.4 million by 2026. As per the latest research citations of the World Health Organization (WHO), approximately 235 million people worldwide are suffering from asthma, and by 2025, an additional increase of 100 million is expected. Asthma spacers are beneficial in mitigating dosing discrepancies associated with inhalers and nebulizers.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Technological advancement and the excellent control and coordination obtained while using metered dose inhalers increase the popularity of aerosols.

Aerochamber is reigning in the product segment of the market for asthma spacers. The latest technological advancements and excellent control and coordination achieved by patients while using metered dose inhalers drive the aerosolizer market’s growth. It has a greater adoption rate as it is available in different mask sizes to fit patients belonging to different age groups. Inspiration has gained acknowledgment in recent years as it is beneficial in increasing the distance between the MDI and mouth, thereby lowering the inhalation of propellants in the oropharyngeal region.

The establishment of premium medicines, as well as a significant increase in the launch of professionalized pharmacy chains, will propel retail pharmacy market growth.

Retail pharmacy is dominating the distribution channel segment for the asthma spacer market. The establishment of premium medicine and a significant rise in the number of pharmacy chains worldwide will provide a positive impetus to the retail pharmacy market’s growth. Increasing demand for metered-dose inhalers has led to a rise in over-the-counter (OTC) sales of asthma spacers in retail pharmacies. E-commerce will capture the market during the forecast period owing to the availability of low-priced asthma spacers in comparison to retail stores due to low overhead costs. Domestic and international vendors exhibit their products online, which provides more options to consumers. Increasing adoption of digital products by consumers facilitates the e-commerce market’s growth.

The rising prevalence of asthma, as well as the location of key players, drive the growth of the asthma spacers market.

In the present scenario, with a 34% market share, North America is the largest regional segment for the asthma spacer market. According to Center for Disease Control and Prevention (CDC) statistics from 2017, the percentage of children under 18 years of age suffering from asthma was 8.4%. Asthma spacers market growth in North America is being driven by rising asthma prevalence and the presence of key players such as Allergan, Inc., CONMED Corporation, Trudell Medical International, and others. Europe is in the second position with a 26% market share, primarily due to the supportive regulatory environment provided by the European Medical Agency (EMA) for the manufacturing and sale of asthma spacers. Asia Pacific represents 16% market growth and will garner stable growth in the near future due to the rising prevalence of respiratory disorders and a well-established e-commerce sector.

Periods of History and Forecast

This research report presents the analysis of each segment from 2016 to 2026, considering 2017 as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments is calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The market is segmented by product, distribution channel, and geography.

Medical device manufacturers producing asthma spacers are AstraZeneca, Plc., Allergan, Inc., CONMED Corporation, Clement Clarke International Limited, GlaxoSmithKline, Plc., Koninklijke Philips N.V., Medical Developments International, Merck & Co., Inc., PARI Respiratory Equipment, Inc., and Trudell Medical International.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key questions are answered in this report.

Who are the major players actively engaged in the asthma spacer market?
What are the drivers, opportunities, and limitations associated with the asthma spacer market?
What is the disease etiology associated with asthma, and what are the problems encountered in the drug dosing of metered-dose inhalers?
What will be the market size and CAGR of aero chambers during the forecast period?
What will be the market performance of the e-commerce sector in the near future?
What is the asthma prevalence rate in North America for the market for asthma spacers?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global AS Market Portraiture
2.2. Global AS Market, by Product, 2017 (US$ Mn)
2.3. Global AS Market, by Distribution Channel, 2017 (US$ Mn)
2.4. Global AS Market, by Geography, 2017 (US$ Mn)

Chapter 3. Asthma Spacers (AS) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global AS Market, by Key Players, 2017

Chapter 4. Global Asthma Spacers (AS) Market, by Product
4.1. Overview
4.2. Aerochamber
4.3. Inspirease
4.4. Optichamber
4.5. Volumatic

Chapter 5. Global Asthma Spacers (AS) Market, by Distribution Channel
5.1. Overview
5.2. Hospital Pharmacy
5.3. Retail Pharmacy
5.4. E-Commerce

Chapter 6. Global Asthma Spacers (AS) Market, by Geography
6.1. Overview
6.2. North America AS Market Analysis, 2016 – 2026
6.2.1. North America AS Market, by Product, 2016 – 2026 (US$ Mn)
6.2.2. North America AS Market, by Distribution Channel, 2016 – 2026 (US$ Mn)
6.2.3. North America AS Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe AS Market Analysis, 2016 – 2026
6.3.1. Europe AS Market, by Product, 2016 – 2026 (US$ Mn)
6.3.2. Europe AS Market, by Distribution Channel, 2016 – 2026 (US$ Mn)
6.3.3. Europe AS Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific AS Market Analysis, 2016 – 2026
6.4.1. Asia Pacific AS Market, by Product, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific AS Market, by Distribution Channel, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific AS Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America AS Market Analysis, 2016 – 2026
6.5.1. Latin America AS Market, by Product, 2016 – 2026 (US$ Mn)
6.5.2. Latin America AS Market, by Distribution Channel, 2016 – 2026 (US$ Mn)
6.5.3. Latin America AS Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East and Africa AS Market Analysis, 2016 – 2026
6.6.1. MEA AS Market, by Product, 2016 – 2026 (US$ Mn)
6.6.2. MEA AS Market, by Distribution Channel, 2016 – 2026 (US$ Mn)
6.6.3. MEA AS Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. AstraZeneca, Plc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Allergan, Inc.
7.3. CONMED Corporation
7.4. Clement Clarke International Limited
7.5. GlaxoSmithkline, Plc.
7.6. Koninklijke Philips N.V.
7.7. Medical Developments International
7.8. Merck & Co., Inc.
7.9. PARI Respiratory Equipment, Inc.
7.10. Trudell Medical International

List of Figures

FIG. 1 Asthma Spacers (AS) Market: Research Methodology
FIG. 2 AS: Market Segmentation
FIG. 3 Global AS Market, by Product, 2017 (US$ Mn)
FIG. 4 Global AS Market, by Distribution Channel, 2017 (US$ Mn)
FIG. 5 Global AS Market, by Geography, 2017 (US$ Mn)
FIG. 6 Attractive Investment Proposition: by Geography, 2017
FIG. 7 Competitive Analysis: Global AS Market, by Key Players, 2017
FIG. 8 Global Aerochamber Market for AS, 2016 – 2026 (US$ Mn)
FIG. 9 Global Inspirease Market for AS, 2016 – 2026 (US$ Mn)
FIG. 10 Global Optichamber Market for AS, 2016 – 2026 (US$ Mn)
FIG. 11 Global Volumatic Market for AS, 2016 – 2026 (US$ Mn)
FIG. 12 Global Hospital Pharmacy Market for AS, 2016 – 2026 (US$ Mn)
FIG. 13 Global Retail Pharmacy Market for AS, 2016 – 2026 (US$ Mn)
FIG. 14 Global E-Commerce Market for AS, 2016 – 2026 (US$ Mn)
FIG. 15 U.S. AS Market, 2016 – 2026 (US$ Mn)
FIG. 16 Canada AS Market, 2016 – 2026 (US$ Mn)
FIG. 17 U.K. AS Market, 2016 – 2026 (US$ Mn)
FIG. 18 Germany AS Market, 2016 – 2026 (US$ Mn)
FIG. 19 Rest of Europe AS Market, 2016 – 2026 (US$ Mn)
FIG. 20 China AS Market, 2016 – 2026 (US$ Mn)
FIG. 21 Japan AS Market, 2016 – 2026 (US$ Mn)
FIG. 22 Rest of Asia Pacific AS Market, 2016 – 2026 (US$ Mn)
FIG. 23 Brazil AS Market, 2016 – 2026 (US$ Mn)
FIG. 24 Mexico AS Market, 2016 – 2026 (US$ Mn)
FIG. 25 Rest of Latin America AS Market, 2016 – 2026 (US$ Mn)
FIG. 26 GCC AS Market, 2016 – 2026 (US$ Mn)
FIG. 27 Rest of MEA AS Market, 2016 – 2026 (US$ Mn)

List of Tables

TABLE 1 Global Asthma Spacers (AS) Market Portraiture
TABLE 2 Global AS Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 3 Global AS Market , by Distribution Channel, 2016 – 2026 (US$ Mn)
TABLE 4 Global AS Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 North America AS Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 6 North America AS Market, by Distribution Channel, 2016 – 2026 (US$ Mn)
TABLE 7 North America AS Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 Europe AS Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 9 Europe AS Market, by Distribution Channel, 2016 – 2026 (US$ Mn)
TABLE 10 Europe AS Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific AS Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific AS Market, by Distribution Channel, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific AS Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America AS Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 15 Latin America AS Market, by Distribution Channel, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America AS Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 Middle East and Africa AS Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 18 Middle East and Africa AS Market, by Distribution Channel, 2016 – 2026 (US$ Mn)
TABLE 19 Middle East and Africa AS Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 20 AstraZeneca, Plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Allergan, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 CONMED Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Clement Clarke International Limited: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 GlaxoSmithkline, Plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Koninklijke Philips N.V.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 Medical Developments International: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 PARI Respiratory Equipment, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Trudell Medical International: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)

Frequently Asked Questions:

What is the size of Asthma Spacers Market?

The market for Asthma Spacers Market is expected to reach US$ 1,824.4 Mn by 2026.

What is the Asthma Spacers Market CAGR?

The Asthma Spacers Market is expected to see significant CAGR growth over the coming years, at 3.8%.

What is the Forecast period considered for Asthma Spacers Market?

The report is forecasted from 2018-2026.

What is the base year considered for Asthma Spacers Market?

The base year of this report is 2017.

Who are the major players in this market?

Allergan, Inc., CONMED Corporation, Clement Clarke International Limited, GlaxoSmithKline, Plc., Koninklijke Philips N.V., Medical Developments International, Merck & Co., Inc are some of the major players in the global market.

Purchase Options

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –